148 related articles for article (PubMed ID: 30365389)
1. Reverse dosimetry modeling of toluene exposure concentrations based on biomonitoring levels from the Canadian health measures survey.
Tohon H; Nong A; Moreau M; Valcke M; Haddad S
J Toxicol Environ Health A; 2018; 81(20):1066-1082. PubMed ID: 30365389
[TBL] [Abstract][Full Text] [Related]
2. Estimation of toluene exposure in air from BMA (S-benzylmercapturic acid) urinary measures using a reverse dosimetry approach based on physiologically pharmacokinetic modeling.
Tohon H; Valcke M; Aranda-Rodriguez R; Nong A; Haddad S
Regul Toxicol Pharmacol; 2021 Mar; 120():104860. PubMed ID: 33406392
[TBL] [Abstract][Full Text] [Related]
3. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
4. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.
Tan YM; Liao KH; Clewell HJ
J Expo Sci Environ Epidemiol; 2007 Nov; 17(7):591-603. PubMed ID: 17108893
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey.
Faure S; Noisel N; Werry K; Karthikeyan S; Aylward LL; St-Amand A
Int J Hyg Environ Health; 2020 Jan; 223(1):267-280. PubMed ID: 31523017
[TBL] [Abstract][Full Text] [Related]
6. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Nong A; McCarver DG; Hines RN; Krishnan K
Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
[TBL] [Abstract][Full Text] [Related]
7. Uncertainty and variability in the exposure reconstruction of chemical incidents--the case of acrylonitrile.
Huizer D; Ragas AM; Oldenkamp R; van Rooij JG; Huijbregts MA
Toxicol Lett; 2014 Dec; 231(3):337-43. PubMed ID: 25050995
[TBL] [Abstract][Full Text] [Related]
8. Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data.
Lyons MA; Yang RS; Mayeno AN; Reisfeld B
Environ Health Perspect; 2008 Aug; 116(8):1040-6. PubMed ID: 18709138
[TBL] [Abstract][Full Text] [Related]
9. Regional variations in human chemical exposures in Canada: A case study using biomonitoring data from the Canadian Health Measures Survey for the provinces of Quebec and Ontario.
Valcke M; Karthikeyan S; Walker M; Gagné M; Copes R; St-Amand A
Int J Hyg Environ Health; 2020 Apr; 225():113451. PubMed ID: 31972364
[TBL] [Abstract][Full Text] [Related]
10. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.
St-Amand A; Werry K; Aylward LL; Hays SM; Nong A
Toxicol Lett; 2014 Dec; 231(2):126-34. PubMed ID: 25455445
[TBL] [Abstract][Full Text] [Related]
11. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Valcke M; Haddad S
J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
[TBL] [Abstract][Full Text] [Related]
12. Physiologically based pharmacokinetic modeling of POPs in Greenlanders.
Sonne C; Gustavson K; Rigét FF; Dietz R; Krüger T; Bonefeld-Jørgensen EC
Environ Int; 2014 Mar; 64():91-7. PubMed ID: 24382481
[TBL] [Abstract][Full Text] [Related]
13. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
14. Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model.
Pierce CH; Dills RL; Morgan MS; Nothstein GL; Shen DD; Kalman DA
Toxicol Appl Pharmacol; 1996 Jul; 139(1):49-61. PubMed ID: 8685908
[TBL] [Abstract][Full Text] [Related]
15. An overview of human biomonitoring of environmental chemicals in the Canadian Health Measures Survey: 2007-2019.
Haines DA; Saravanabhavan G; Werry K; Khoury C
Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):13-28. PubMed ID: 27601095
[TBL] [Abstract][Full Text] [Related]
16. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
[TBL] [Abstract][Full Text] [Related]
17. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
18. A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.
Phillips MB; Sobus JR; George BJ; Isaacs K; Conolly R; Tan YM
Regul Toxicol Pharmacol; 2014 Aug; 69(3):434-42. PubMed ID: 24845241
[TBL] [Abstract][Full Text] [Related]
19. Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability.
Ring CL; Pearce RG; Setzer RW; Wetmore BA; Wambaugh JF
Environ Int; 2017 Sep; 106():105-118. PubMed ID: 28628784
[TBL] [Abstract][Full Text] [Related]
20. Human biomonitoring reference values for metals and trace elements in blood and urine derived from the Canadian Health Measures Survey 2007-2013.
Saravanabhavan G; Werry K; Walker M; Haines D; Malowany M; Khoury C
Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):189-200. PubMed ID: 27776932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
